Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hebold

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Infectious Diseases|April 1, 1979
Investigations in mice on the potentiation of resistance to infections by a new immunostimulant compoundU Bicker, A E Ziegler, G Hebold
Experimental Pathology|January 1, 1985
Incidence of spontaneous tumors in laboratory ratsG Bode, F Hartig, G Hebold, et al.
Teratology|June 1, 1985
A postulated mechanism of beta-sympathomimetic induction of rib and limb anomalies in rat fetusesH Sterz, G Sponer, P Neubert, et al.
Experientia|October 15, 1979
Reduction of acute toxicity of cyclophosphamide and X-rays by the new immunomodulating compound BM 12.531U Bicker, K D Friedberg, G Hebold, et al.
Experimentelle Pathologie|January 1, 1978
Animal experiments on the compensation of the immunosuppressive action of cyclophosphamide by 2-[-2-cyanaziridinyl-(1)-]-2-[-2-carbamoylaziridinyl-(1)]-propane BM 12 531U Bicker, G Hebold, A E Ziegler, et al.
Experimental Pathology|January 1, 1986
Investigations on the exogenous influencing of the spontaneous tumour rate in ratsF Hartig, J Vollmar, G Bode, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Infectious Diseases|April 1, 1979
Investigations in mice on the potentiation of resistance to infections by a new immunostimulant compoundU Bicker, A E Ziegler, G Hebold
Experimental Pathology|January 1, 1985
Incidence of spontaneous tumors in laboratory ratsG Bode, F Hartig, G Hebold, et al.
Teratology|June 1, 1985
A postulated mechanism of beta-sympathomimetic induction of rib and limb anomalies in rat fetusesH Sterz, G Sponer, P Neubert, et al.
Experientia|October 15, 1979
Reduction of acute toxicity of cyclophosphamide and X-rays by the new immunomodulating compound BM 12.531U Bicker, K D Friedberg, G Hebold, et al.
Experimentelle Pathologie|January 1, 1978
Animal experiments on the compensation of the immunosuppressive action of cyclophosphamide by 2-[-2-cyanaziridinyl-(1)-]-2-[-2-carbamoylaziridinyl-(1)]-propane BM 12 531U Bicker, G Hebold, A E Ziegler, et al.
Experimental Pathology|January 1, 1986
Investigations on the exogenous influencing of the spontaneous tumour rate in ratsF Hartig, J Vollmar, G Bode, et al.
Pageof 3